Supreme Financial Statements From 2010 to 2024

Supreme Cannabis financial statements provide useful quarterly and yearly information to potential The Supreme Cannabis investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Supreme Cannabis financial statements helps investors assess Supreme Cannabis' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Supreme Cannabis' valuation are summarized below:
The Supreme Cannabis does not presently have any fundamental trend indicators for analysis.
Check Supreme Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Supreme main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Supreme financial statements analysis is a perfect complement when working with Supreme Cannabis Valuation or Volatility modules.
  
This module can also supplement various Supreme Cannabis Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

The Supreme Cannabis OTC Stock Return On Equity Analysis

Supreme Cannabis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Supreme Cannabis Return On Equity

    
  -7.85  
Most of Supreme Cannabis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Supreme Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, The Supreme Cannabis has a Return On Equity of -7.85. This is 67.25% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.

Supreme Cannabis Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Supreme Cannabis's current stock value. Our valuation model uses many indicators to compare Supreme Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Supreme Cannabis competition to find correlations between indicators driving Supreme Cannabis's intrinsic value. More Info.
The Supreme Cannabis is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Supreme Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Supreme Cannabis' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Supreme Cannabis' earnings, one of the primary drivers of an investment's value.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Supreme OTC Stock

If you are still planning to invest in Supreme Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Supreme Cannabis' history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets